baber/WOPTO huggingface dataset:
Patent JP-3581906-B2 (JP)
IPC: C07C67/02
Filed: 1994-07-08
Granted: 2004-10-27
Abstract: PCT No. PCT/AT94/00088 Sec. 371 Date Feb. 27, 1996 Sec. 102(e) Date Feb. 27, 1996 PCT Filed Jul. 8, 1994 PCT Pub. No. WO95/02661 PCT Pub. Date Jan. 26, 1995A method for the preparation of fatty acid alkyl esters by transesterification, in particular catalytic transesterification, of triglycerides, wherein from a reaction mixture, in which the transesterification is carried out, an ester phase and a glycerol phase containing fatty acids, fatty acid salts and/or other fatty acid compounds are formed, which are separated from each other, characterized in that the fatty acids, the fatty acid salts and/or other fatty acid compounds are separated from the glycerol phase, esterified with an alcohol and recycled to a different reaction mixture, in which a further transesterification is carried out. The method according to the invention allows for a transesterification with a high yield of fatty acid esters.
Patent JP-H0781112-B2 (JP)
IPC: B05D7/16
Filed: 1991-03-14
Abstract: PCT No. PCT/EP91/00481 Sec. 371 Date Oct. 30, 1992 Sec. 102(e) Date Oct. 30, 1992 PCT Filed Mar. 14, 1991 PCT Pub. No. WO91/14712 PCT Pub. Date Oct. 3, 1991.The invention relates to a process for the production of a multicoat coating in which the aqueous topcoat composition contains a water-thinnable polyacrylate resin which has a hydroxyl value of 40 to 200, an acid value of 20 to 100 and a glass transition temperature (TG) of -40 DEG  C. to +60 DEG  C., and can be prepared by adding a mixture (I) of a (meth)acrylic acid ester, a copolymerizable hydroxyl-containing monomer and, if appropriate, a further ethylenically unsaturated monomer to an organic solvent and carrying out free-radical polymerization and adding, at the end of the addition of the mixture (I), a mixture of a monomer containing carboxyl groups and a monomer free from carboxyl groups and continuing the polymerization.
Patent JP-3258659-B2 (JP)
IPC: A61K31/22
Filed: 1992-03-05
Granted: 2002-02-18
Abstract: This invention relates to phenyl amidines derivatives having the following formula <CHEM> or a pharmaceutically acceptable salt which are useful in the inhibition of platelet aggregation. This invention also relates to pharmaceutical compositions of such phenyl amidines derivatives.
Patent JP-3657003-B2 (JP)
IPC: A23L7/104
Filed: 1994-09-14
Granted: 2005-06-08
Abstract: PCT No. PCT/SE94/00857 Sec. 371 Date Nov. 21, 1995 Sec. 102(e) Date Nov. 21, 1995 PCT Filed Sep. 14, 1994 PCT Pub. No. WO95/07628 PCT Pub. Date Mar. 23, 1995A homogeneous and stable cereal suspension having the taste and aroma of natural oats, as well as a method for the preparation thereof, is described. The cereal suspension contains intact  beta -glucans from the starting material and is prepared by A) dry- or wet-grinding rolled oats or otherwise heat- and water-treated oats to meal, B) suspending the oatmeal in water, if the meal has been produced by dry grinding, C) optionally centrifuging or decanting the suspension in order to remove coarse fibre particles, D) treating the suspension with  beta -amylase, which specifically gene-rates maltose units and has no glucanase and proteinase effect, to a viscosity of 3-0.1 Pas in the shear rate range of 10-100 s-1, E) treating the suspension with  alpha -amylase, which specifically gene-rates maltose units and has no glucanase and proteinase effect, to a viscosity of <0.5 Pas in the shear rate range of 10-100 s-1, F) preferably homogenising the enzyme-treated suspension, and G) subjecting the suspension to UHT treatment (UHT=Ultra High Temperature) in order to obtain a sterile product while inactivating the enzymes added.
Patent JP-3007146-B2 (JP)
IPC: A61Q5/02
Filed: 1991-06-19
Granted: 2000-02-07
Abstract: Method of treating individuals with alopecia or having inferior quality hair, by administering to the scalp of said individuals an effective amount of ketoconazole. Novel compositions comprising as an active ingredient ketoconazole and an inert carrier.
Patent JP-2942630-B2 (JP)
IPC: C07D311/66
Filed: 1991-06-27
Granted: 1999-08-30
Abstract: This invention relates to compounds of Formula I and the stereoisomers and pharmaceutically acceptable salts thereof    <IMAGE>  +TR   <IMAGE>   wherein R is alkyl, alkenyl, alkynyl, or cycloalkylalkyl; R1 is alkyl; R2 is hydrogen, alkyl; R6 is alkyl; n is 1 to 5; p is 0 to 6; x is 0 or 2; and R4 and R5 are independently hydrogen or alkyl or together with N form a cycloalkylamine. The compounds of Formula I are leukotriene B4 antagonists and are useful as anti-inflammatory agents and in treating disease conditions mediated by LTB4.
Patent JP-3516455-B2 (JP)
IPC: C12N9/52
Filed: 1996-11-07
Granted: 2004-04-05
Abstract: There are provided hyperthermostable proteases having an amino acid sequences represented by SEQ ID Nos. 1, 3 and 5 of the Sequence Listing or functional equivalents thereof and hyperthermostable protease genes encoding those hyperthermostable protease. There is also disclosed a process for preparation of a hyperthermostable protease by culturing a transformant containing the gene.
Patent JP-3015920-B2 (JP)
IPC: A61F2/76
Filed: 1994-02-15
Granted: 2000-03-06
Abstract: The present invention relates to a prosthesis having a substantially rigid leg member, wherein most of the bending takes place about a confined ankle region relatively low to the ground, and in a flexible toe and ankle section, wherein the bending of the prosthesis more closely resembles the bending of a normal ankle joint. The confined bending helps to reduce the amount of horizontal deflection caused along the ankle section by the upward deflection of the prosthesis. The present invention also comprises a tubular leg member that is detachable from the ankle and foot member, and a heel member extending rearwardly from the foot member which is also detachable therefrom.
Patent JP-3944241-B2 (JP)
IPC: C12N15/12
Filed: 1996-11-25
Granted: 2007-07-11
Abstract: The present invention relates to AUR-1 and/or AUR-2 polypeptides, nucleic acids encoding such polypeptides, cells, tissues and animals containing such nucleic acids, antibodies to such polypeptides, assays utilizing such polypeptides, and methods relating to all of the foregoing. Methods for treatment, diagnosis, and screening are provided for AUR-1 and/or AUR-2 related diseases or conditions characterized by an abnormal interaction between an AUR-1 and/or AUR-2 polypeptide and an AUR-1 and/or AUR-2 binding partner.
Patent JP-3785599-B2 (JP)
IPC: G02C7/04
Filed: 1996-01-22
Granted: 2006-06-14
Abstract: PCT No. PCT/EP96/00246 Sec. 371 Date Jul. 30, 1997 Sec. 102(e) Date Jul. 30, 1997 PCT Filed Jan. 22, 1996 PCT Pub. No. WO96/24075 PCT Pub. Date Aug. 8, 1996The invention relates to a novel process for the production of mouldings, in particular contact lenses, in which a water-soluble, crosslinkable polymer is crosslinked in solution, and to mouldings, in particular contact lenses, obtainable by this process. The present invention likewise relates to novel water-soluble, crosslinkable polymers, in particular those comprising units of formula (III or IIIa), in which R1 and R2, independently of one another, are hydrogen, a C1-C8alkyl group, an aryl group or a cyclohexyl group, where these groups can be monosubstituted or polysubstituted, R3 is hydrogen or a C1-C4 alkyl group, and R4 is an -OH- or -NH- bridge; and to crosslinked polymers made from these novel water-soluble, crosslinkable polymers, to a process for the preparation of the novel water-soluble, crosslinkable polymers and the homopolymers and copolymers obtainable therefrom, to mouldings made from said homopolymers or copolymers, in particular contact lenses made from these homopolymers or copolymers, and to a process for the production of contact lenses using said homopolymers or copolymers.    <IMAGE>  (III)   <IMAGE>  (IIIa)
Patent JP-3523878-B2 (JP)
IPC: G01N33/50
Filed: 1995-03-06
Granted: 2004-04-26
Abstract: A cyanide-free method and reagent for determining the concentration of total hemoglobin in a whole blood sample accurately in less than 10 seconds comprising a ligand selected from the group consisting of imidiazole, imidazole derivatives, N-hydroxyacetamide, N-hydroxyl amine, pyridine, oxazole, thiazole, pyrazole, pyrimidine, purine, quinoline, and isoquinoline, and a surfactant with strong erythrolytic capability selected from the group consisting of lauryl dimethylamine oxide and octylphenoxy polyethoxyethanol. The reagent pH is adjusted to about 11 to about 14. Rapid mixing of the reagent with a blood sample leads to the formation of a stable chromogen whose absorbance can be measured between 540 and 550 nm. The cyanide-free reagent is ideal for use on an automated high through-put clinical hematology analyzer.
Patent JP-4221063-B2 (JP)
IPC: A61P33/02
Filed: 1997-01-23
Granted: 2009-02-12
Abstract: PCT No. PCT/EP97/00310 Sec. 371 Date Jul. 31, 1998 Sec. 102(e) Date Jul. 31, 1998 PCT Filed Jan. 23, 1997 PCT Pub. No. WO97/28804 PCT Pub. Date Aug. 14, 1997The present invention relates to dust free, easily flowable and dosable granular compositions containing triazine, having a particle size distribution of between 40 and 400 mu  and an upper limit of particle size at 2000 mu , which can be effectively mixed with feed for administration to animals.
Patent ES-2319954-B2 (ES)
Title: Mango para una herramienta distal y sistema de cirugia endoscopica o laparoscopica.
Inventor: SANCIBRIAN HERRERA RAMON
IPC: A61B17/29
Filed: 2008-10-22
Granted: 2010-10-14
Abstract: Mango para una herramienta distal y sistema de
cirugía endoscópica o laparoscópica. 
     Mango para una herramienta distal (17) de
cirugía laparoscópica provisto  de medios para accionar dicha
herramienta distal, los cuales comprenden  una empuñadura y dos
palancas solidarias (3,4) que están configuradas para  accionar la
herramienta distal y están dispuestas una a cada lado de la 
empuñadura, de manera que una de las palancas está configurada para
ser  accionada por el dedo pulgar y la otra palanca está configurada
para ser  accionada por el dedo índice, mientras que la empuñadura
está configurada  para ser asida por los otros tres dedos junto con
la palma de la mano.  Las palancas (3; 4) comprenden un brazo
exterior (3a; 4a) y un brazo interior,  habiendo un espacio entre
ambos brazos para alojar un dedo, de manera que  cada palanca está
configurada para que el dedo ejerza una fuerza de cierre  sobre el
brazo interior y una fuerza de apertura sobre el brazo exterior.
Patent ES-2536798-B2 (ES)
Title: Sistema y método de protección 100% tierra estátor basado en la medida de tercer armónico autoajustable
Inventor: PLATERO GAONA CARLOS ANTONIO
IPC: H02H7/06
Filed: 2014-10-30
Granted: 2017-02-03
Abstract: Sistema y método de protección 100% tierra estátor basado en la medida de tercer armónico autoajustable.#Método y sistema de protección 100% tierra estator para máquinas síncronas basado en la medida del tercer armónico que se ajusta en función de las condiciones de operación de la máquina, evitando así disparos no deseados.#Para ello se mide el tercer armónico producido por cada devanado de la máquina. A partir de esta medida se calcula el valor teórico que debe tener el tercer armónico en el neutro o en los terminales de dicha máquina. Y por último este valor teórico se compara con la medida en el neutro o en los terminales, determinando que existe defecto si no son iguales.
Patent AU-2001279748-B2 (AU)
Title: Herbicides
Inventor: FRISCH GERHARD
IPC: A01N25/30
Filed: 2001-07-13
Granted: 2005-11-24
Abstract: The present invention relates to a herbicidal composition comprisingd) one or more herbicidal active substances from the group of the grass-controlling sulfonamides,e) one or more silicone surfactants, andf) one or more humectants.The composition according to the invention is outstandingly suitable for controlling a variety of harmful plants.
Patent AU-2002304635-B2 (AU)
Title: Process for the preparation of an xanthophyll
Inventor: FLACHER RICHARD
IPC: C07C45/28
Filed: 2002-04-18
Granted: 2006-09-28
Abstract: The present invention relates to a process for the preparation of an xanthophyll, and in particular to a process for the preparation of an xanthophyll through the oxidation of a carotenoid in the presence of hydrogen peroxide and an iodine-containing compound. In particular, the process of the invention applies to the oxidation of  beta -carotene to produce canthaxanthin, and to the oxidation of lutein or zeaxanthin to produce astaxanthin.
Patent AU-2002311784-B2 (AU)
Title: Acute pharmacologic augmentation of psychotherapy with enhancers of learning or conditioning
Inventor: DAVIS MICHAEL
IPC: A61K31/00
Filed: 2002-03-28
Granted: 2007-11-22
Abstract: Methods for treating an individual with a psychiatric order with a pharmacologic agent that enhances learning or conditioning in combination with a session of psychotherapy are provided. These methods of the invention encompass a variety of methods of psychotherapy, and psychodynamically oriented psychotherapy, and psychiatric orders including fear and anxiety disorders, addictive disorders, addictive disorders including substance-abuse disorders, and mood disorders. The pharmacologic agents used for the methods of the present invention are ones that generally enhance learning or conditioning, including those that increase the level of norepinephrine in the brain, those that increase the level of acetylcholine in the brain, and those that enhance N-methyl-D-aspartate (NMDA) receptor transmission in the brain.
Patent AU-2002314816-B2 (AU)
Title: Deployable ultrasound medical transducers
Inventor: MAKIN INDER RAJ S
IPC: A61B17/28
Filed: 2002-05-28
Granted: 2007-06-21
Abstract: An ultrasound medical treatment system includes an end effector insertable into a patient. The end effector includes a tissue-retaining device. The tissue-retaining device includes a first tissue-retaining member having an ultrasound medical-treatment transducer and includes a second tissue-retaining member. The first and second tissue-retaining members are operatively connected together to retain patient tissue between the first and second tissue-retaining members and to release patient tissue so retained. In one example, the second tissue-retaining member has an ultrasound reflector. In the same or a different example, the ultrasound medical-treatment transducer is an ultrasound imaging and medical-treatment transducer.
Patent AU-2002324302-B2 (AU)
Title: Aluminium electrowinning cells with sloping foraminate oxygen-evolving anodes
Inventor: NORA VITTORIO DE
IPC: C25C3/06
Filed: 2002-08-29
Granted: 2008-01-10
Abstract: A cell for the electrowinning of aluminum (50) from alumina, comprises an inclined plate-like or grid-like open anode structure (25) which has a generally v-shaped configuration in cross-section. The anode structure (25) has a downwardly-oriented sloping electrochemically active surface that is generally v-shaped in cross-section and spaced above an upwardly-oriented corresponding sloping cathode surface (11) by an anode-cathode gap (40) in which alumina dissolved in a circulating electrolyte (60) is electrolysed. The anode structure (25) has a plurality of anode through-passages (45) distributed thereover for an up-flow of alumina-depleted electrolyte (60) from the anode-cathode gap (40). One or more electrolyte guide members (30,30′,30″) located above the open anode structure (25) is/are arranged to guide substantially all the up-flowing alumina-depleted electrolyte (60) to an alumina feeding area (63), where it is enriched with alumina and then over and around an upper end (27) of the generally v-shaped plate-like or grid-like anode structure (25) into the anode-cathode gap (40). Alumina-enriched electrolyte (60) can be fed into a lower end and/or into an upper end of the anode-cathode gap (40).
Patent AU-2003237952-B2 (AU)
Title: Method for the transmission of data packets in a mobile radio system and corresponding mobile radio system
Inventor: WEGNER FRANK
IPC: H04Q7/38
Filed: 2003-06-17
Granted: 2005-12-08
Abstract: A method transmits data packets in a mobile radio system and corresponding mobile radio system. The method permits an immediate transmission of data packets to the receiver station along a new transmission path, after a handover of a connection along a transmission path, between a transmission station and a receiver station, to a new transmitting station. The new transmission station thus receives no information regarding the transmission status of data packets, which were transmitted before the handover of the connection.
Patent AU-2003292198-B2 (AU)
Title: Hydroxyethylamine derivatives for the treatment of Alzheimer's disease
Inventor: VESEY DAVID R
IPC: C07D211/76
Filed: 2003-12-03
Granted: 2007-09-06
Abstract: The present invention relates to novel hydroxyethylamine compounds having Asp2 (beta-secretase, BACE1 or Memapsin) inhibitory activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases characterised by elevated beta-amyloid levels or beta-amyloid deposits, particularly Alzheimer's disease.
Patent AU-2003293938-B2 (AU)
Title: Process for the conversion of heavy feedstocks such as heavy crude oils and distillation residues
Inventor: MARCHIONNA MARIO
IPC: C10G67/04
Filed: 2003-12-12
Granted: 2010-05-20
Abstract: A process for the conversion of heavy feedstocks using hydrotreatment, distillation or flash, and deasphalting that includes mixing a heavy feedstock with a hydrogenation catalyst and subjecting the thus-formed mixture to a hydrotreatment reactor for reaction with one or more of hydrogen and hydrogen sulfide to form a first product stream; subjecting the first product stream to a distillation or flash to form a plurality of distillate fractions; and recycling heavies from the distillation residue and/or tar by deasphalting in the presence of a solvent; where the hydrotreatment reaction product is pre-separated under high pressure to form light and heavy fractions and sending the heavy fraction to the distillation and/or flash.
Patent AU-2004224985-B2 (AU)
Title: Artificial intervertebral disc
Inventor: CLIFT JOSEPH
IPC: A61F2/44
Filed: 2004-11-03
Granted: 2009-05-07
Abstract: An artificial intervertebral disc (10) including housing members (12,14) including spaced inner surfaces (16,18) facing each other and oppositely facing outer surfaces (20,22) for engaging spaced apart intervertebral surfaces; self-adjusting bearing mechanisms (23) operatively disposed between the inner surfaces for moving relative to the housing members to adjust and compensate for vertebral disc motion; and positioning ring (33) for controlling motion and position of the bearing mechanisms and for absorption of compressive loads.
Patent AU-2004256048-B2 (AU)
Title: Process for the oligomerization of olefins in Fischer-Tropsch derived feeds
Inventor: HARRIS THOMAS V
IPC: C10G25/03
Filed: 2004-06-03
Granted: 2011-11-03
Abstract: A process for oligomerizing the olefins present in a Fischer-Tropsch derived condensate containing a mixture of olefins and oxygenates which comprises (a) reducing significantly the oxygenates present in the Fischer-Tropsch condensate; (b) contacting the Fischer-Tropsch derived condensate having significantly reduced oxygenates with an ionic liquid catalyst in an oligomerization zone under oligomerization reaction conditions; and (c) recovering from the oligomerization zone a Fischer-Tropsch derived product having molecules characterized by a higher average molecular weight and increased branching as compared to the Fischer-Tropsch derived condensate.
Patent AU-2004294356-B2 (AU)
Title: Steering rack manufacture
Inventor: JAEGGI JOHANN FRIEDERICH
IPC: B62D3/12
Filed: 2004-12-03
Granted: 2007-12-20
Abstract: A die apparatus and method for performing a flashless forging operation to manufacture the toothed portion of a steering rack. The die apparatus includes first and second die members and at least one punch member, each having a forming surface shaped substantially as an obverse of a portion of the toothed portion. At least a portion of the forming surface of the first die member is shaped substantially as the obverse of the teeth of the rack. The first and second die members are moveable towards each other to a closed position, thereby partially forging the toothed portion from a blank placed in the die apparatus, and forming a substantially closed cavity defined by the forming surfaces. The punch member is adapted to move into the cavity once the die members are in the closed position, thereby completing the forging operation.
Patent AU-2005205994-B2 (AU)
Title: Self adjusting instrument
Inventor: HOF REPHAEL
IPC: A61C3/02
Filed: 2005-01-24
Granted: 2010-05-27
Abstract: The invention is an instrument for cleaning and/or shaping and/or widening a root canal. The instrument is an inflatable balloon, which allows the inner volume enclosed by the instrument, its outer contour, or both to change as a result of the forces exerted upon it while working, thereby shaping the instrument to the three-dimensional contour of the channel. The outer surface of the balloon is coated with abrasive material. A preferred embodiment of the instrument is an endodontic file for use in the cleaning, shaping, and widening stages of a root canal procedure.
Patent AU-2005306579-B2 (AU)
Title: Bioactive compositions
Inventor: LICHTI GOTTFRIED
IPC: A61K47/42
Filed: 2005-11-18
Granted: 2012-01-19
Abstract: This invention relates to a bioactive composition comprising: (d) pH sensitive bioactive agent (e) an edible carboxylic acid containing moiety and (f) an edible alkalising moiety, wherein the proportion of said moieties and active agent provide pH control such that (i) when 400mg of said composition is added to 20 ml of 0.033 normal hydrochloric acid and at a temperature of 37 +/- 3°C, the pH reaches a value in the range 4 to 8, and (ii) when 400mg of said composition is added to 20 ml of deionised water at pH 7 and at a temperature of 37 +/- 3°C, the pH reaches a value less than 8.5.
Patent AU-2006254834-B2 (AU)
Title: Treatment of patients with cancer therapy
Inventor: DAMOKOSH ANDREW I
IPC: G16B40/10
Filed: 2006-06-08
Granted: 2012-09-20
Abstract: The present invention is directed to the identification of predictive markers that can be used to determine whether patients with cancer are clinically responsive or non-responsive to a therapeutic regimen prior to treatment. In particular, the present invention is directed to the use of certain individual and/or combinations of predictive markers, wherein the expression of the predictive markers correlates with responsiveness or non-responsiveness to a therapeutic regimen. Thus, by examining the expression levels of individual predictive markers and/or predictive markers comprising a marker set, it is possible to determine whether a therapeutic agent, or combination of agents, will be most likely to reduce the growth rate of tumors in a clinical setting.
Patent AU-2006272634-B2 (AU)
Title: Targeted integration and expression of exogenous nucleic acid sequences
Inventor: URNOV FYODOR
IPC: C07H21/04
Filed: 2006-07-26
Granted: 2013-01-24
Abstract: Disclosed herein are methods and compositions for targeted integration of a exogenous sequence into a predetermined target site in a genome for use, for example, in protein expression and gene inactivation.